They can also cause rare and occasionally severe side effects including acute pancreatitis and acute gallbladder diseases as well as intestinal obstruction and gastroparesis
"Amylin receptor agonism for obesity treatment: Clinical development of cagrilintide." Diabetes, Obesity and Metabolism , 25(4), 891-903
Members also get access to other prescription medications for sexual health, hair growth and more
Of the patients that switched, nearly half of them paid out of pocket for branded GLP-1 drugs, while the rest relied on commercial insurance to pay for branded drugs, revealing a significant cost barrier to switching
Findings in both the type 2 diabetes and obesity groups were similar in a secondary analysis using 1:1 propensity score matching plus an exact match of variables differing by 20% or more between groups
Within one to two weeks of the last injection, most patients experience return of previous hunger patterns and food cravings